Adolescents with severe obesity: outcomes of participation in an intensive obesity management programme
2014; Wiley; Volume: 10; Issue: 4 Linguagem: Inglês
10.1111/ijpo.261
ISSN2047-6310
AutoresPaola De Luca, Elizabeth Dettmer, Michael Khoury, Preeti Grewal, Cedric Manlhiot, Brian W. McCrindle, Catherine S. Birken, Jill Hamilton,
Tópico(s)Health and Lifestyle Studies
ResumoSummary Background Most interventions for childhood obesity are randomized controlled studies. Less is known about the effectiveness of clinical obesity programmes. Objective To assess outcomes in adolescents participating in the S ick K ids T eam O besity M anagement P rogram ( STOMP ) vs. a comparison group of obese adolescents. Methods Severely obese adolescents ( n = 75) in STOMP (15.1 ± 1.8 years, body mass index [ BMI ] 44.8 ± 7.8 kg m −2 ) were compared with adolescents ( n = 41) not in the programme (14.9 ± 2.0 years, BMI 34.5 ± 8.0 kg m −2 ). Outcomes were change in BMI , cardiometabolic, psychological and health behaviour measures. Results At 6 months, STOMP patients' BMI was unchanged (0.08 ± 0.3; P = 0.79) and they reported improvements in quality of life and depression (−3.6 ± 1.4; P = 0.009), and increases in measures of readiness to change ( RTC ). Between‐group differences in change between 0 and 6 months, in favour of STOMP patients, were observed for homeostatic measurement assessment‐insulin resistance ( HOMA‐IR ; −2.7 ± 1.0; P = 0.007), depression scores (−3.5 ± 1.7; P = 0.04), diet‐ RTC (0.6 ± 0.2; P < 0.001) and physical activity (1.7 ± 0.9; P = 0.05). At 12 months, STOMP patients increased BMI (0.8 ± 0.5; P = 0.07), but they exhibited decreased waist circumference (−7.4 ± 2.1 cm; P = 0.001) and HOMA‐IR (−1.9 ± 0.6; P = 0.002). Between‐group differences in change between 0 and 12 months, in favour of STOMP patients, were observed for waist circumference (−5.9 ± 2.4 cm; P = 0.01), HOMA‐IR (−2.9 ± 0.7; P < 0.001) and diet‐ RTC (0.9 ± 0.2; P < 0.001). Conclusions STOMP participants did not experience a significant reduction in BMI but did have improvements in cardiometabolic, psychological and health behaviour outcomes. Evaluation of paediatric clinical obesity programmes using multiple measures is essential to understanding real‐world outcomes.
Referência(s)